Home > Drugs A-Z > IFEREX 150

IFEREX 150 (Nnodum Pharmaceuticals)

Available Formats

Dosage Form Package Information Links
CAPSULE 100 CAPSULE in 1 BOTTLE (63044-203-01) Label Information
CAPSULE 10 BLISTER PACK in 1 BOX, UNIT-DOSE (63044-203-61) > 10 CAPSULE in 1 BLISTER PACK Label Information

Complete IFEREX 150 Information

  • Statement of identity

    iFEREX 150 is an easily assimilated source of iron for treatment of uncomplicated iron deficiency anemia.


  • Healthn Claims

    iFerex 150 is indicated for the prevention and treatment of iron deficiency anemia and/or nutritional megaloblastic anemias.


  • Warning

    Accidental overdose of iron-containing products is a leading cause in fatal poisoning of children under 6. Keep this product out of reach of children.  In case of accidental overdose, call a doctor or poison control center immediately.


  • Dosage and Administration

    Adults: One or two capsules daily or as directed by a physician.


  • Precautions

    General: The type of anemia and underlying cause or causes should be determined before starting therapy with iFerex 150. Since the

    anemia may be a result of systemic disturbance, such as recurrent blood loss, the underlying cause or causes should be corrected, if possible.


  • Safe Handling Warning

    KEEP THIS AND ALL DRUGS OUT OF REACH OF CHILDREN.

    DISPENSE IN A TIGHT, LIGHT-RESISTANT CONTAINER WITH A RESISTANT CLOSURE.

    STORAGE: Store at 20oC-25​oC (68​o- 77oF); excursions to 15oC-30oC (59o-86oF)


  • Principal Display Panel - IFEREX 150

    iFEREX 150 10x10

    ZIKs  63044-0203-01

    iFEREX 150

    Polysaccharide Iron

    Complex Hematinic

    100 Capsules

    EACH CAPSULE CONTAINS:

    Iron (elemental).....................150 mg

     (polysaccharide iron complex 326.1 mg)

    INACTIVE INGREDIENTS: Black Iron oxide,FD&C Red #28, FD&C Yellow # 10, FD&C blue #1, FD&C red #40, FD&C yellow #6,gelatin, magnesium stearate, microcrystalline cellulose,Red Iron Oxide, and Titanium Dioxide

    DESCRIPTION: iFerex 150 is a brown and orange capsule with marking "ziks 0203".

    It is a product of ferric iron complexed to a low molecular weight polysaccharide.

    INDICATIONS AND USAGE: iFerex 150 is indicated for the prevention and treatment of

    iron deficiency anemia and/or nutritional megaloblastic anemias.

    CONTRAINDICATIONS: iFerex 150 is indicated in patients with a known hypersensitivity

    to any of the components of this product. Hemochromatosis and hemosiderosis are

    contraindications to iron therapy.

    ADVERSE REACTIONS: Adverse reactions with iron therapy may include constipation,

    diarrhea, nausea, vomiting, dark stools, and abdomibal pain. Adverse reactions with iron

    tharapy are usually transient.

    WARNING: Accidental overdose of iron-containing products is a leading cause in

    fatal poisoning of children under 6. Keep this product out of reach of children.

    In case of accidental overdose, call a doctor or poison control center immediately.

    PRECAUTIONS: General: The type of anemia and underlying cause or causes

    should be determined before starting therapy with iFerex 150.  Since the

    anemia may be a result of systemic disturbance, such as recurrent blood loss,

    the underlying cause or causes should be corrected, if possible.

    DOSAGE AND ADMINISTRATION: Adults: One or two capsules daily or as directed by a physician.

    KEEP THIS AND ALL DRUGS OUT OF REACH OF CHILDREN.

    ​DISPENSE IN A TIGHT, LIGHT-RESISTANT CONTAINER WITH A RESISTANT CLOSURE.

    STORAGE: Store at 20​o​C-25​o​C (68​o​- 77​​o​F); excursions to 15​o​C-30​o​C (59​o-86​o​F)

    HOW SUPPLIED: iFerex 150 capsules are supplied in 100 capsule per bottle.

    Distributed by Nnodum Pharmaceuticals, Cincinnati, OH 45229

    NP 6/18/09

    LC-10872

    3 63044 20301 2

    iFEREX 150 -100 tab


  • INGREDIENTS AND APPEARANCE
    IFEREX 150 
    polysaccharide-iron complex capsule
    Product Information
    Product Type DIETARY SUPPLEMENT Item Code (Source) NHRIC:63044-203
    Route of Administration ORAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    IRON (UNII: E1UOL152H7) (IRON - UNII:E1UOL152H7) IRON 150 mg
    Inactive Ingredients
    Ingredient Name Strength
    FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
    FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  
    FD&C RED NO. 40 (UNII: WZB9127XOA)  
    FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
    GELATIN (UNII: 2G86QN327L)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    FERRIC OXIDE RED (UNII: 1K09F3G675)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NHRIC:63044-203-61 10 in 1 BOX, UNIT-DOSE
    1 10 in 1 BLISTER PACK
    2 NHRIC:63044-203-01 100 in 1 BOTTLE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    dietary supplement 03/01/2018
    Supplement Facts
    Serving Size : Serving per Container :
    Amount Per Serving % Daily Value
    color
    color
    imprint
    shape
    size (solid drugs) 7 mm
    scoring 1
    Labeler - Nnodum Pharmaceuticals (960457273)
    Establishment
    Name Address ID/FEI Business Operations
    PD Pharmatech, LLC. 063753431 manufacture